On 12 February 2018
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 12 February 2018, to approve the standalone and consolidated unaudited financial results of the Company for the quarter ended December 31, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
